These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Proteases and their receptors as mediators of inflammation-associated colon cancer. Trusevych EH; MacNaughton WK Curr Pharm Des; 2015; 21(21):2983-92. PubMed ID: 26004412 [TBL] [Abstract][Full Text] [Related]
84. Acute pancreatitis: proteinase-activated receptor-2 as Dr. Jekyll and Mr. Hyde. Matej R; Housa D; Olejár T Physiol Res; 2006; 55(5):467-474. PubMed ID: 16343048 [TBL] [Abstract][Full Text] [Related]
85. Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Heuberger DM; Schuepbach RA Thromb J; 2019; 17():4. PubMed ID: 30976204 [TBL] [Abstract][Full Text] [Related]
86. CSCI/RCPSC Henry Friesen Lecture. Mentors and the butterfly effect: triggers for discovering signalling by proteinases via proteinase-activated receptors (PARs) and more. Hollenberg MD Clin Invest Med; 2012 Feb; 35(6):E378-91. PubMed ID: 23217564 [TBL] [Abstract][Full Text] [Related]
87. The role of coagulation in chronic inflammatory disorders: a jack of all trades. Borensztajn KS; von der Thüsen JH; Spek CA Curr Pharm Des; 2011; 17(1):9-16. PubMed ID: 21222644 [TBL] [Abstract][Full Text] [Related]
88. Diversification of PAR signaling through receptor crosstalk. Lee-Rivera I; López E; López-Colomé AM Cell Mol Biol Lett; 2022 Sep; 27(1):77. PubMed ID: 36088291 [TBL] [Abstract][Full Text] [Related]
89. Recent advances in synthesis of PAR ligands as therapeutic strategy for inflammatory diseases. Severino B; Santagada V; Perissutti E; Fiorino F; Frecentese F; De Angelis F; Esposito A; Caliendo G Mini Rev Med Chem; 2009 Jun; 9(6):653-63. PubMed ID: 19519491 [TBL] [Abstract][Full Text] [Related]
90. Bugs and guts: it's good to talk? Farthing MJ J R Coll Physicians Lond; 1999; 33(3):267-75. PubMed ID: 10402578 [No Abstract] [Full Text] [Related]
91. [Tissular distribution of the alloantigens of the secretory groups (digestive groups) in the dog]. Zweibaum A; Dussaulx E C R Acad Hebd Seances Acad Sci D; 1973 Jun; 276(24):3237-9. PubMed ID: 4199022 [No Abstract] [Full Text] [Related]
92. [Pancreatitis and protease-activated receptor]. Hirota M; Fujimura Y; Ichihara A; Araki N; Baba H Nihon Shokakibyo Gakkai Zasshi; 2006 Aug; 103(8):918-23. PubMed ID: 16912457 [No Abstract] [Full Text] [Related]
93. Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases. Heuberger DM; Schuepbach RA Thromb J; 2019; 17():22. PubMed ID: 31708692 [TBL] [Abstract][Full Text] [Related]
96. The functional role of protease-activated receptors on contractile responses by activation of Ca Sung TS; Lu H; Sung J; Yeom JH; Perrino BA; Koh SD Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G921-G931. PubMed ID: 30260688 [TBL] [Abstract][Full Text] [Related]
97. Tryptase promotes breast cancer angiogenesis through PAR-2 mediated endothelial progenitor cell activation. Qian N; Li X; Wang X; Wu C; Yin L; Zhi X Oncol Lett; 2018 Aug; 16(2):1513-1520. PubMed ID: 30008831 [TBL] [Abstract][Full Text] [Related]
98. From engineering to editing the rat genome. Meek S; Mashimo T; Burdon T Mamm Genome; 2017 Aug; 28(7-8):302-314. PubMed ID: 28752194 [TBL] [Abstract][Full Text] [Related]
99. Evolution of the protease-activated receptor family in vertebrates. Jin M; Yang HW; Tao AL; Wei JF Int J Mol Med; 2016 Mar; 37(3):593-602. PubMed ID: 26820116 [TBL] [Abstract][Full Text] [Related]
100. Protease-activated receptors modulate excitability of murine colonic smooth muscles by differential effects on interstitial cells. Sung TS; Kim HU; Kim JH; Lu H; Sanders KM; Koh SD J Physiol; 2015 Mar; 593(5):1169-81. PubMed ID: 25641660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]